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MicroevolutionIntroduction: The advent of molecular typing using MIRU-VNTR mini-satellites has largely
facilitated tuberculosis (TB) molecular epidemiological studies. Apart from detecting the
chains of transmission and risk factors, these markers have also allowed to study the
phenomena of mixed strain infections versus microevolutionary events.
Methods: An initial set of Mycobacterium tuberculosis strains (n = 161) genotyped using
spoligotyping and MIRU-VNTRs in Guyana and Suriname was evaluated for indications
mixed strain infections (characterized by the detection of double alleles in 2 or more MIRU
loci) versus ‘‘in-patient’’ microevolutionary events (characterized by the detection of double
alleles in a single locus).
Results: The present study hereby reports evidence of microevolution in 3.7% (n = 6/161) of
the studied population, vs. 0.6% (n = 1/161) for mixed infection. The strains belonged to
three different spoligotyping-based lineages, namely the T (SITs 44, 53, and 1081), Haarlem
(SIT47), and EAI (SITs 72 and 349) lineages, while 1 isolate (SIT237) could not be assigned to
any lineage.
Discussion: By comparing these results on microevolutionary cases (n = 6) to 112,000 strains
present in the SITVIT2 database, evidence is presented that in 2/6 cases (each case corre-
sponding to 2 patterns due to MIRU double bands), one of the patterns corresponded to a
shared type found exclusively in Suriname or Guyana. Phylogenetic analysis showed that
no spoligotyping lineage in particular was more prone to microevolutionary events in this
study’s sample. Overall, the observations fortify the awareness regarding the existence of
microevolution and polyclonal TB infections which has important implications for patient
care.
 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.[1]. It has long been assumed that a patient is infected by aIntroduction
Tuberculosis (TB) remains a major global health problem, hav-
ing caused 9 million new cases and 1.5 million deaths in 2013single strain of Mycobacterium tuberculosis (MTB) at a time.
Nonetheless, the advent of molecular epidemiological tech-
niques has led to increasing reports of mixed strain infectionsadeloupe,
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the past 15 years [2–6; reviewed in 7]. MIRU-VNTR typing [8,9],
widely applied in molecular epidemiologic studies, facilitates
the detection of polyclonal infections as the presence of more
than one strain in a sample is likely to lead to the detection of
multiple alleles in a number of loci. Depending on the number
of implicated loci, two distinct mechanisms are considered
responsible for the presence of such multiple alleles; ‘‘in-
patient’’ microevolution of the infecting clone in case of the
detection of double alleles in a single locus as opposed to
simultaneous infection with two distinct MTB strains when
two or more loci are concerned [2–4,10]. Microevolution can
of course affect any genotypic marker, for example, a strain
may evolve by losing a spacer of the initial spoligotype profile.
As the molecular clock of spoligotyping profiles is lower than
that of MIRU-VNTRs [11], evolutionary changes are much less
frequent in the former. Moreover, ‘‘in-patient’’ microevolution
within the DR-locus (i.e., the locus targeted by spoligotyping
technique) is not detectable unless single colonies from serial
isolates (containing the initial isolate vs. recently evolved iso-
lates) are obtained and analyzed separately. Since the present
report presents essentially MIRU-VNTR data, hereafter the
focus will be on microevolution concerning this particular
marker. Most often, studies on polyclonal and multiple strain
infections were conducted in settings with high TB burden [2–
5]. Nevertheless, they have also been observed in areas with
moderate TB incidence [6]. The present study reports evi-
dence for clonal heterogeneity and mixed-infection observed
in a recent epidemiologic study on isolates from Guyana and
Suriname [12] based on MIRU-VNTRs.
Materials and methods
Clinical isolates
The MTB bacterial isolates (n = 7) described in this study were
genotyped in the course of a recent epidemiological study on
clinical isolates (n = 161) from Guyana and Suriname [12].
They were part of a convenience sample of clinical isolates
sent to the Caribbean Epidemiology Centre (CAREC), Trinidad,
for identification and drug susceptibility testing (DST) [13].
Genotyping and database comparison
The initial set of strains (n = 161) was subjected to standard
spoligotyping [14] and 15-loci MIRU-VNTR typing [9] in the fol-
lowing order: MIRU-4, MIRU-10, MIRU-16, MIRU-26, MIRU-31,
MIRU-40, ETR-A, ETR-C, QUB-11b, QUB-26, QUB-4156, Mtub04,
Mtub21, Mtub30, and Mtub39. The results from each of the 15
loci were combined to create a 15-digit allelic profile, and a
cluster was defined as two or more strains sharing identical
spoligotypes and 15-loci MIRU patterns. The obtained profiles
were compared with SITVIT2, a proprietary database of
the Pasteur Institute of Guadeloupe which is an updated
version of SpolDB4 [15] and SITVITWEB [16], and assigned to
a SIT (spoligo-international-type) and/or 15-MIT (15-loci
MIRU-international-type) respectively, if they matched at least
one other profile in the database or classified as an orphan
(no match found).From the initially published study [12], strains for which
multiple bands were repeatedly obtained for P1 locus were
excluded from epidemiological analysis (n = 7), and were fur-
ther investigated in the present study to elucidate the phe-
nomena of polyclonal infections versus microevolutionary
events identified by MIRU-VNTRs. For this purpose, all poly-
merase chain reactions (PCRs) were repeated twice to confirm
the presence of multiple alleles in a given MIRU locus.
Phylogenetical analysis
Major phylogenetic clades were assigned according to the sig-
natures provided in the database defining 62 genetic lin-
eages/sublineages. These include various MTB complex
members, as well as rules defining major lineages/sublin-
eages for MTB sensu-stricto, namely: Beijing clade, the
Central Asian (CAS) clade and 2 sublineages, the East
African-Indian (EAI) clade and 9 sublineages, the Haarlem
(H) clade and 3 sublineages (including H3/Ural-1 and
H4/Ural-2 sublineages), the Latin American-Mediterranean
(LAM) clade, its 12 sublineages (note that sublineages LAM7-
TUR and LAM10-CAM are now referred to as Turkey and
Cameroon lineages), the ancestral ‘‘Manu’’ family and 3 sub-
lineages, the S clade, the IS6110-low-banding X clade and 3
sublineages, and an ill-defined T clade with 5 sublineages.
BioNumerics v6.6 (Applied Maths NV, Sint-Martens-Latem,
Belgium) was used to construct a minimum spanning tree
(MST) based on spoligotypes and 15-loci MIRU VNTR profiles
and nodes differing in a maximum of two genotypic markers
(i.e., VNTR locus or spoligo-spacer) were grouped in order to
highlight single locus variants (SLVs) and double locus variants
(DLVs).
Results
The results obtained along with schematic representation of
microevolution and polyclonal infection, the mechanisms
involved, and genotyping results are summarized in Table 1
and Figs. 1 and 2. As listed in Table 1, 7 patient isolates
(n = 5 from Suriname and n = 2 from Guyana) repeatedly dis-
played multiple alleles in one or more MIRU locus. As
schematically illustrated in Fig. 1, they were considered sug-
gestive of microevolution if a single locus (n = 6 strains) was
implicated, and mixed infection if several loci were con-
cerned (n = 1 strain). Given that the original epidemiological
study [12] covered n = 154 isolates with unambiguous profiles,
the rate of patients harboring clonal subpopulations was 3.7%
(n = 6/161) in the studied population, and 0.6% (n = 1/161)
showing evidence of mixed strain infection. Their genotypic
profiles and basic demographic data are shown in Table 1;
the strains belonged to three different spoligotyping-based
lineages, namely the T (SITs 44, 53, and 1081), Haarlem
(SIT47), and EAI (SITs 72 and 349) lineages. One isolate
(SIT237) could not be assigned to any lineage. The patients’
mean age was 48 years, ranging from 14 to 83 years. With
the exception of the youngest patient (a female), all other
patients were male. All strains were pan-susceptible.
In n = 6/7 samples double alleles were detected in a single
locus. In accordance with current conventions [2–5,10], these
Table 1 – Isolates showing multiple alleles for one or more VNTR loci.
Origin Age/ Sex DST* HIV** SIT*** Clade VNTR profile MIT15 Conclusion 




SUR 83/M S NA 47 H1 2425332/334732343 Orphan Clonal variant 
SUR 48/M S – 53 T1 231532/3342522222 Orphan Clonal variant 
GUY 54/M S NA 72 EAI1-SOM 5432537254126/924 
Orphan/ 
MIT872 Clonal variant 
SUR 43/M S – 237 Unknown 243233343/4732343 Orphan Clonal variant 
GUY 14/M S NA 349 EAI1-SOM 5432539274128/C26 
Orphan/ 
MIT876 Clonal variant 
SUR 56/M S – 1081 T 2436/831336833442 Orphan Clonal variant 
* DST (drug-susceptibility testing): S, pansusceptible.
** HIV serology: (+) positive, () negative, NA, not available.
*** Note that strains with SIT44 and SIT47 further showed a third, unspecific band for the multiple allele loci, observed
right above the larger of the two specific amplification products.
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same strain. The respective patients correspond to what is
depicted as an index case for the establishment of a new
SLV in a given population in Fig. 1A (i.e., patient harboring
stain A and A1). On the other hand, a single isolate
(SIT44/T5) showed multiple alleles in six loci indicating a
simultaneous infection with two different MTB strains (strain
A + strain B), classified as polyclonal infection (Fig. 1B).
In parallel, it was also checked to see if any of the two
MIRU profiles detected in each of the patients harboring
microevolved strains (Table 1, except SIT44/T5) corresponded
to profiles that had been observed before by comparing to
112,000 strains present in SITVIT2 database. In case one of
the detected profiles matched a 15-MIT profile detected
earlier in the region, one could tentatively assume that this
profile corresponded to the original infecting strain, while
the other profile represents the newly evolved variant.
Interestingly, one of the VNTR profiles detected in a patient
harboring the microevolved strain (SIT72/EAI1-SOM) matched
only 2 strains (Fig. 2, shown by red arrow), being exclusively
reported in Guyana (a previous study [12]). Interestingly, a
third strain in the same study represented a SLV of this same
15-MIT pattern, indicating that strains belonging to the clonal
group SIT72/EAI1-SOM/15-MIT872 have been implicated in
microevolutionary events in the past. Likewise, the profile of
another microevolved strain (SIT349/EAI1-SOM) matched
exclusively 2 strains reported in Suriname (a previous study
[12]), belonging to the clonal group SIT349/EAI1-SOM/
15-MIT876 (Fig. 2, shown by blue arrow). The fact that these
profiles (i.e., 15-MIT872 and 15-MIT876, Table 1) correspond
to patterns actively circulating in the region (Fig. 2) suggests
that the patient initially contracted the strains with a
shared-type pattern which later evolved to give an orphan
pattern. The profiles detected in the 4 other patients
(Table 1) were exclusively orphan patterns. Note that Fig. 2
illustrates the population structure of the global sample stud-
ied (n = 154 strains from Guyana and Suriname), excluding
the 7 strains showing multiple copies in one or more MIRU
loci (Table 1). In the MST shown, various lineages are shownby different colors, and profiles differing by a change in 1
marker (SLV), vs. 2 markers (DLV) are shown by bold vs. thin
connecting lines, globally highlighted by a gray background.Discussion
In this study, 5 loci have been implicated in in-patient
microevolution events, namely Mtub 21 (VNTR 1955, changing
twice) and MIRU 26 (VNTR 2996), MIRU 40 (VNTR 802), ETR A
(VNTR 2165) and QUB 11b (VNTR 2163b) all changing once.
These loci were found to be among the 7 most variable loci
of the MIRU-typing scheme in a large-scale evaluation con-
ducted by Supply et al. [9]. These authors furthermore
reported the observation of changes in MIRU 40 and QUB
11b, in a series of epidemiologically linked isolates.
In order to verify, if there is a particular group of spoligotyp-
ing profiles more prone to microevolution in the 15 VNTR loci
than others, a spoligoforest (http://www.emi.unsw.edu.au/
spolTools/) was constructed using the spoligotypes of all
n = 161 clinical isolates from Guyana and Suriname, and spolig-
otypes observed in microevolved isolates were marked. The
visual assessment showed that spoligotypes of microevolved
strains were scattered over different branches of the spoligo-
forest without any obvious branch preferences. It was, there-
fore, concluded that no spoligotyping lineage is particularly
prone to be involved in microevolution in this sample (data
not shown). Regarding other potential predisposing factors
for in-patient microevolution, diagnostic delay has been
reported in connection with patients harboring clonal variants
in a study conducted in Spain [6]. However, seeing as similar
mutation rates have been observed during latency, active dis-
ease and in logarithmically growing cultures in a recent study
[17], the time passed since the primo infection might be more
influential than the lapse of time between disease outbreak
and diagnosis.
The transmission of microevolved strains may entrain the
appearance SLVs in a series of epidemiologically linked cases
(Fig. 1, transmission of A1 strains; [9]). However, these events
Fig. 1 – Microevolution (A) and polyclonal infection (B): schematic representation of involved mechanisms and genotyping
results.
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ologic unrelatedness [18,19]. Nevertheless, the presence of
SLVs in a given strain population is an echo of past evolution-
ary events, and the abundance of closely related patterns sug-
gests that the clones in question and their ancestors have
been circulating in the region for a long time and/or subject
to heavy active transmission, which permitted the accumula-
tion of numerous changes to the original genotype. To check
for such traces in this study population, an MST was con-
structed based on spoligotypes and 15-loci MIRU profiles
(Fig. 2), and nodes that differed in a maximum of two geno-
typic markers were grouped. While most groups contain only
two nodes, the two most frequent spoligotypes of the T family
(SIT53 and SIT131) stand out as they group a number of SLVs
(marked by bold connecting lines) around a central MIRU-
pattern. In order to evaluate the genetic diversity of both
SITs on a global level, available data were extracted fromSITVIT2, and the number of distinct MIRU15 profiles (shared
and orphan) was determined. The same assessment was car-
ried out for a ubiquitous pattern SIT50/H3 in SITVIT2, acting
as a control. Interestingly, the diversity of VNTR profiles
observed among SIT53 strains is considerably higher than
that observed for the two other patterns (SIT50, SIT131).
This observation is probably due to a higher ongoing evolu-
tion of SIT53; indeed, in the SITVIT2 database, as much as
47.6% (n = 325) of SIT53 strains with 15-loci MIRU data
(n = 683) are recorded as orphan vs. only 29% (n = 171) of the
SIT50 strains with 15-loci MIRU data (n = 589). Future studies
should elucidate if this is simply due to the widespread occur-
rence and transmission of SIT53/T1, or if they are more prone
to genetic diversification. It is also possible that the two go
hand-in-hand, since subtle differences in the infectivity of
microevolved MTB variants co-infecting the same patient
have been observed [20], and microevolution has been linked
Fig. 2 – MST of isolates from patients from Guyana and Suriname harboring monoclonal M. tuberculosis infections: profiles
differing by a change in one marker (bold connecting line) or two markers are depicted on gray background (when applicable,
SIT and MIT15 are specified).
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Thus, predisposition for evolution of SIT53/T1 strains may
have favored their ubiquitous spread in all human popula-
tions and macro-regions [16]. Finally, the last isolate showed
multiple alleles in 6 loci indicating a simultaneous infection
with two different MTB strains. This isolate displayed
SIT44/T5, a profile that can emerge as a result of almost
11,000 possible combinations of spoligotypes [22].
Little is known about predisposing factors or patient char-
acteristics associated with mixed strain infections as the
number of patients found to harbor such infections is usually
too low to allow for meaningful statistical analysis. In this
sense, the present study is no exception and did not allow
for drawing any statistically meaningful conclusions. On the
same lines, it could not conclude if HIV infection increased
the vulnerability for mixed strain infections as suggested in
a previous study from Kampala, Uganda [2], even though
the only patient harboring a mixed-strain infection in this
study was HIV+ (Table 1).
It has been previously argued that mixed infections, par-
ticularly in cases where co-infecting strains display different
drug susceptibility patterns (i.e., heteroresistance), have a
negative impact on treatment outcome [7]. However, thesingle case of mixed infection represented by SIT44/T5 in
the present study was pansusceptible, not allowing for a
conclusion on this particular aspect.
Conclusions
Overall, the observations in the present study fortify the
awareness regarding the existence of clonally complex TB
infections that has been growing in recent years. The
realization that polyclonal infections constitute a reality has
important implications for patient care considering the
potential occurrence of heteroresistance [7]. Further research
is needed to better document the frequency of mixed
infections and their relevance for disease progression and
treatment outcome in affected patients, as well as their
implication for vaccine development.
Nonetheless, it is important to keep in mind that
MIRU-VNTRs analyze only a very small part of the mycobac-
terial genome and therefore might underestimate the extent
of heterogeneity within a patient or population. As whole
genome sequencing (WGS) is becoming more accessible,
studies using this technique are expected to provide a more
accurate assessment (reviewed in [23]).
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